Maximilian Tollner
Overview
Explore the profile of Maximilian Tollner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang S, Tollner M, Wang D, Minnert C, Durst K, Caron A, et al.
Nat Commun
. 2025 Feb;
16(1):1305.
PMID: 39900632
Small adjustments in atomic configurations can significantly impact the magnetic properties of matter. Strain, for instance, can alter magnetic anisotropy and enable fine-tuning of magnetism. However, the effects of these...
2.
Speer C, Tollner M, Benning L, Bartenschlager M, Kim H, Nusshag C, et al.
Viruses
. 2023 Aug;
15(8).
PMID: 37632120
Emerging omicron subtypes with immune escape lead to inadequate vaccine response with breakthrough infections in immunocompromised individuals such as Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) patients. As AAV is considered...
3.
Kuhn T, Speer C, Morath C, Bartenschlager M, Kim H, Beimler J, et al.
Transplantation
. 2023 Jan;
107(5):1139-1150.
PMID: 36617671
Background: The impaired immune response to coronavirus disease 2019 (COVID-19) vaccination in kidney transplant recipients (KTRs) leads to an urgent need for adapted immunization strategies. Methods: Sixty-nine KTRs without seroconversion...
4.
Benning L, Morath C, Kuhn T, Bartenschlager M, Kim H, Beimler J, et al.
Front Med (Lausanne)
. 2022 Sep;
9:958293.
PMID: 36059830
Seroconversion rates after COVID-19 vaccination are significantly lower in kidney transplant recipients compared to healthy cohorts. Adaptive immunization strategies are needed to protect these patients from COVID-19. In this prospective...
5.
Benning L, Morath C, Bartenschlager M, Kim H, Reineke M, Beimler J, et al.
Am J Transplant
. 2022 Apr;
22(7):1873-1883.
PMID: 35384272
Seroconversion after COVID-19 vaccination is impaired in kidney transplant recipients. Emerging variants of concern such as the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants pose an increasing threat to these...
6.
Tollner M, Speer C, Benning L, Bartenschlager M, Nusshag C, Morath C, et al.
J Clin Med
. 2022 Mar;
11(6).
PMID: 35330069
Background: To characterize humoral response after standard anti-SARS-CoV-2 vaccination in Rituximab-treated patients and to determine the optimal time point after last Rituximab treatment for appropriate immunization. Methods: Sixty-four patients who...
7.
Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, et al.
Front Immunol
. 2022 Mar;
13:840136.
PMID: 35309320
Hemodialysis patients are at high risk for severe COVID-19, and impaired seroconversion rates have been demonstrated after COVID-19 vaccination. Humoral immunity wanes over time and variants of concern with immune...
8.
Benning L, Morath C, Bartenschlager M, Reineke M, Tollner M, Nusshag C, et al.
Clin Microbiol Infect
. 2022 Feb;
28(7):1024.e7-1024.e12.
PMID: 35124261
Objectives: Humoral immunity wanes over time after two-dose BNT162b2 vaccination. Emerging variants of concern, such as the B.1.617.2 (delta) variant, are increasingly responsible for breakthrough infections owing to their higher...
9.
Speer C, Tollner M, Benning L, Klein K, Bartenschlager M, Nusshag C, et al.
Ann Rheum Dis
. 2022 Jan;
81(4):593-595.
PMID: 35012926
No abstract available.
10.
Benning L, Morath C, Bartenschlager M, Reineke M, Tollner M, Nusshag C, et al.
Kidney Int
. 2021 Dec;
101(3):639-642.
PMID: 34954213
No abstract available.